Leritrelvir

DRUG3 trials

Sponsors

Guangdong Raynovent Biotech Co., Ltd

Conditions

Drug Drug InteractionElderKidney Impairment

Phase 1

Drug-durg Interaction of Leritrelvir(RAY1216) With Midazolam, Omeprazole, Rosuvastatin, Verapamil, and Rifampin

CompletedNCT06031454

Guangdong Raynovent Biotech Co., LtdDrug Drug Interaction

Start: 2023-09-01End: 2023-12-31Updated: 2024-04-16

Pharmacokinetics of Leritrelvir(RAY1216) in Participants With Severe Kidney Disease

CompletedNCT06160622

Guangdong Raynovent Biotech Co., LtdKidney Impairment

Start: 2023-09-26End: 2023-12-12Updated: 2024-02-02

Pharmacokinetics of Leritrelvir(Ray1216) in Elder Participants

CompletedNCT06169085

Guangdong Raynovent Biotech Co., LtdElder

Start: 2023-08-24End: 2023-10-11Updated: 2024-04-16

Related Papers

Pharmacokinetic Drug-Drug Interaction of Leritrelvir in Healthy Chinese Volunteers: A Single-Arm, Open-Label, Dual-Cohort Study.

2026-05-01